In connection with the reduction in force, Evofem Biosciences, Inc. terminated the employment of Katherine Atkinson as its Chief Commercial Officer, effective March 17, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0154 USD | +2.32% | +1.31% | -75.78% |
1st Jan change | Capi. | |
---|---|---|
-75.78% | 9L | |
+31.37% | 59TCr | |
-2.83% | 36TCr | |
+20.34% | 33TCr | |
+5.47% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+11.16% | 17TCr | |
-0.07% | 16TCr |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Terminates Katherine Atkinson as Chief Commercial Officer